Growth Stock Network »
Better Buy: Aphria vs. Canopy Growth
If you’re looking to buy a marijuana stock, Aphria (NYSE:APHA) and Canopy Growth (NYSE:CGC) should probably be on your list for consideration. They’re two of the largest Canadian cannabis producers in terms of production
Read More »The Only Pure-Play Marijuana Dividend Stock Upped Its Payout for a Second Straight Quarter
The marijuana industry is a lot of things. It’s a potentially once-in-a-generation growth opportunity for investors, with up to $75 billion in full-year sales expected by the time 2030 rolls around. This rapid sales
Read More »
1 Hot Marijuana Stock to Buy in June
No industry is as hot as the marijuana industry right now. Within the U.S. alone, sales of state-regulated cannabis will grow to more than $22 billion by 2022, according to the Arcview Group, up
Read More »
3 Marijuana Stocks That Are Breaking the Mold
Marijuana isn’t just another growth industry. It has the potential to be a once-in-a-generation growth opportunity for patient investors who have a keen eye for this fast-paced industry. Between 2018 and 2030, various Wall
Read More »
Tilray Resolves a Small Issue but Bigger Problems Remain
Chances are that investors would struggle to find a bigger (or buzzier) long-term growth opportunity at the moment than marijuana. Although black market cannabis sales continue to dominate, legal channel sales are soaring as
Read More »
2 Top Cannabis Stocks to Consider Buying Now
Last year, cannabis stocks entered the mainstream, thanks to the legalization of recreational marijuana in Canada and the increasing momentum of the legalization movement in the United States. Investor interest in this space remains in
Read More »
Better Buy: Canopy Growth vs. Scotts Miracle-Gro
If you’re considering buying either Canopy Growth (NYSE:CGC) or Scotts Miracle-Gro (NYSE:SMG), you probably wish you could turn back the hands of time. Both stocks are up more than 50% so far in 2019. The nice gain is a
Read More »10 Numbers to Focus On When Canopy Growth Reports Its Fourth-Quarter Results
Sure, earnings season may have passed for the lion’s share of brand-name companies, but that doesn’t mean earnings reports cease altogether. Next week, the biggest name in all of cannabis, Canopy Growth (NYSE:CGC), will be dishing
Read More »
Why are shares of Hexo Corp. trading down 6% today?
It’s been a great year for HEXO Corp. (NYSEMKT:HEXO) so far. The company reported tremendous revenue growth in its first full quarter of sales in the Canadian adult-use recreational marijuana market. It announced the acquisition of Newstrike Brands.
Read More »
Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today
What happened Shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) were shooting 18.9% higher as of 10:57 a.m. EDT on Tuesday. The big jump came after the biotech announced that it received a new patent for treating autism spectrum disorders
Read More »
